ALBANY, N.Y.--(BUSINESS WIRE)--
AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical
devices for the minimally-invasive treatment of cancer and peripheral
vascular disease, today announced that it will report its fiscal 2011
second quarter financial results on Tuesday, January 4, 2011, after the
close of the U.S. financial markets.
Jan Keltjens, President and Chief Executive Officer, and Joseph Gersuk,
Executive Vice President and Chief Financial Officer, will host an
investment community conference call beginning at 4:30 p.m. Eastern Time
on January 4, 2011, to discuss the quarter's results and to answer
To participate in the live call by telephone, please dial +1 (877)
Those interested in listening to the conference call live via the
Internet may do so by visiting the Investor Relations section of
AngioDynamics' Web site at http://investors.angiodynamics.com.
To listen to the live call, please go to the Web site 15 minutes prior
to its start to register, download and install the necessary audio
software. The conference call will also be archived on the Web site.
AngioDynamics, Inc. is a leading provider of innovative medical devices
used by interventional radiologists, surgeons and other physicians for
the minimally-invasive treatment of cancer and peripheral vascular
disease. AngioDynamics' diverse product lines include market-leading
radiofrequency and irreversible electroporation ablation systems,
vascular access products, angiographic products and accessories,
dialysis products, angioplasty products, drainage products, thrombolytic
products, embolization products and venous products. More information is
available at www.angiodynamics.com.
Joseph Gersuk, CFO, 800-772-6446 x1608
EVC Group, Inc.
Sherk/ Greg Gin
EVC Group, Inc.
Source: AngioDynamics, Inc.
News Provided by Acquire Media